First-line systemic therapy for metastatic breast cancer and management of pleural effusion-Reference-Cited by-同舟云学术

First-line systemic therapy for metastatic breast cancer and management of pleural effusion

Published:1995-12 Issue:10 Volume:6 Page:1033-1043
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Perrone F.,Carlomagno C.,De Placido S.,Lauria R.,Morabito A.,Bianco A.R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/6/10/1033/372097/6-10-1033.pdf

Reference93 articles.

1. A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer;Tannock,1988

2. A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast;Baum,1980

3. Improving the quality of life during chemotherapy for advanced breast cancer;Coates;N Engl J Med,1987

4. A controlled study in the use of combined drug therapy for metastatic breast cancer;Brunner;Cancer,1975

5. Analysis of survival by tumor response;Andersen;J Clin Oncol,1983

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Malignant Pleural Effusions in Breast Cancer;Breast Disease;2019

2. Management of Malignant Pleural Effusions in Breast Cancer;Breast Disease;2016

3. Prolonged pleural catheters in the management of pleural effusions due to breast cancer;J THORAC DIS;2014

4. Malignant pleural effusion in breast cancer 12 years after mastectomy that was successfully treated with endocrine therapy;American Journal of Case Reports;2013

5. A CASE OF RECURRENT BREAST CARCINOMA WHERE THE INITIAL MANIFESTATION WAS A PLEURAL EFFUSION 23 YEARS AFTER SURGERY;Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association);2009